BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 16786549)

  • 1. The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies.
    Lamers LM; McDonnell J; Stalmeier PF; Krabbe PF; Busschbach JJ
    Health Econ; 2006 Oct; 15(10):1121-32. PubMed ID: 16786549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inconsistencies in TTO and VAS values for EQ-5D health states.
    Lamers LM; Stalmeier PF; Krabbe PF; Busschbach JJ
    Med Decis Making; 2006; 26(2):173-81. PubMed ID: 16525171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The transformation of utilities for health states worse than death: consequences for the estimation of EQ-5D value sets.
    Lamers LM
    Med Care; 2007 Mar; 45(3):238-44. PubMed ID: 17304081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Social valuation of EQ-5D health states: the Chilean case.
    Zarate V; Kind P; Valenzuela P; Vignau A; Olivares-Tirado P; Munoz A
    Value Health; 2011 Dec; 14(8):1135-41. PubMed ID: 22152184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dutch Tariff for the Five-Level Version of EQ-5D.
    M Versteegh M; M Vermeulen K; M A A Evers S; de Wit GA; Prenger R; A Stolk E
    Value Health; 2016 Jun; 19(4):343-52. PubMed ID: 27325326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Measuring the quality of life in economic evaluations: the Dutch EQ-5D tariff].
    Lamers LM; Stalmeier PF; McDonnell J; Krabbe PF; van Busschbach JJ
    Ned Tijdschr Geneeskd; 2005 Jul; 149(28):1574-8. PubMed ID: 16038162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of population health status in six european countries: results of a representative survey using the EQ-5D questionnaire.
    König HH; Bernert S; Angermeyer MC; Matschinger H; Martinez M; Vilagut G; Haro JM; de Girolamo G; de Graaf R; Kovess V; Alonso J;
    Med Care; 2009 Feb; 47(2):255-61. PubMed ID: 19169128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the assessment of preferences for health and duration: maximal endurable time and better than dead preferences.
    Stalmeier PF; Lamers LM; Busschbach JJ; Krabbe PF
    Med Care; 2007 Sep; 45(9):835-41. PubMed ID: 17712253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of a Danish TTO value set for EQ-5D health states.
    Wittrup-Jensen KU; Lauridsen J; Gudex C; Pedersen KM
    Scand J Public Health; 2009 Jul; 37(5):459-66. PubMed ID: 19411320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valuing health: does enriching a scenario lead to higher utilities?
    Peeters Y; Stiggelbout AM
    Med Decis Making; 2009; 29(3):334-42. PubMed ID: 19264727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single European currency for EQ-5D health states. Results from a six-country study.
    Greiner W; Weijnen T; Nieuwenhuizen M; Oppe S; Badia X; Busschbach J; Buxton M; Dolan P; Kind P; Krabbe P; Ohinmaa A; Parkin D; Roset M; Sintonen H; Tsuchiya A; de Charro F
    Eur J Health Econ; 2003 Sep; 4(3):222-31. PubMed ID: 15609189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating EuroQol EQ-5D scores from Population Healthy Days data.
    Jia H; Lubetkin EI
    Med Decis Making; 2008; 28(4):491-9. PubMed ID: 18556640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The gap effect: discontinuities of preferences around dead.
    Stalmeier PF; Busschbach JJ; Lamers LM; Krabbe PF
    Health Econ; 2005 Jul; 14(7):679-85. PubMed ID: 15744750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The burden of depressive disorders in Germany - results from the European Study of the Epidemiology of Mental Disorders (ESEMeD)].
    Günther OH; Friemel S; Bernert S; Matschinger H; Angermeyer MC; König HH
    Psychiatr Prax; 2007 Sep; 34(6):292-301. PubMed ID: 17806016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The EQ-5D in alcohol dependent patients: relationships among health-related quality of life, psychopathology and social functioning.
    Günther O; Roick C; Angermeyer MC; König HH
    Drug Alcohol Depend; 2007 Jan; 86(2-3):253-64. PubMed ID: 16930855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Logical inconsistencies in survey respondents' health state valuations -- a methodological challenge for estimating social tariffs.
    Devlin NJ; Hansen P; Kind P; Williams A
    Health Econ; 2003 Jul; 12(7):529-44. PubMed ID: 12825206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Policy decisions from a societal perspective: local or national evaluation of health related quality of life not necessary].
    Buskens E
    Ned Tijdschr Geneeskd; 2005 Jul; 149(28):1553-5. PubMed ID: 16038157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The validity of EQ-5D US preference weights in liver transplant candidates and recipients.
    Russell RT; Feurer ID; Wisawatapnimit P; Pinson CW
    Liver Transpl; 2009 Jan; 15(1):88-95. PubMed ID: 19109831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of differences between patient and general population EQ-5D-3L values on the mean tariff scores of different patient groups.
    Little MH; Reitmeir P; Peters A; Leidl R
    Value Health; 2014 Jun; 17(4):364-71. PubMed ID: 24968996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional differences in health status in China: population health-related quality of life results from the National Health Services Survey 2008.
    Sun S; Chen J; Johannesson M; Kind P; Xu L; Zhang Y; Burström K
    Health Place; 2011 Mar; 17(2):671-80. PubMed ID: 21334961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.